purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Study Coverage
1.1 Non-Invasive Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Non-Invasive Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Artificial Pancreas
1.2.3 Needle Free Injector
1.2.4 Digital Respiratory Devices
1.2.5 Other
1.3 Market by Application
1.3.1 Global Non-Invasive Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Non-Invasive Drug Delivery Sales Estimates and Forecasts 2017-2028
2.2 Global Non-Invasive Drug Delivery Revenue Estimates and Forecasts 2017-2028
2.3 Global Non-Invasive Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Non-Invasive Drug Delivery Sales by Region
2.4.1 Global Non-Invasive Drug Delivery Sales by Region (2017-2022)
2.4.2 Global Sales Non-Invasive Drug Delivery by Region (2023-2028)
2.5 Global Non-Invasive Drug Delivery Revenue by Region
2.5.1 Global Non-Invasive Drug Delivery Revenue by Region (2017-2022)
2.5.2 Global Non-Invasive Drug Delivery Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Non-Invasive Drug Delivery Sales by Manufacturers
3.1.1 Global Top Non-Invasive Drug Delivery Manufacturers by Sales (2017-2022)
3.1.2 Global Non-Invasive Drug Delivery Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-Invasive Drug Delivery in 2021
3.2 Global Non-Invasive Drug Delivery Revenue by Manufacturers
3.2.1 Global Non-Invasive Drug Delivery Revenue by Manufacturers (2017-2022)
3.2.2 Global Non-Invasive Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Non-Invasive Drug Delivery Revenue in 2021
3.3 Global Non-Invasive Drug Delivery Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Non-Invasive Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Non-Invasive Drug Delivery Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-Invasive Drug Delivery Sales by Type
4.1.1 Global Non-Invasive Drug Delivery Historical Sales by Type (2017-2022)
4.1.2 Global Non-Invasive Drug Delivery Forecasted Sales by Type (2023-2028)
4.1.3 Global Non-Invasive Drug Delivery Sales Market Share by Type (2017-2028)
4.2 Global Non-Invasive Drug Delivery Revenue by Type
4.2.1 Global Non-Invasive Drug Delivery Historical Revenue by Type (2017-2022)
4.2.2 Global Non-Invasive Drug Delivery Forecasted Revenue by Type (2023-2028)
4.2.3 Global Non-Invasive Drug Delivery Revenue Market Share by Type (2017-2028)
4.3 Global Non-Invasive Drug Delivery Price by Type
4.3.1 Global Non-Invasive Drug Delivery Price by Type (2017-2022)
4.3.2 Global Non-Invasive Drug Delivery Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Non-Invasive Drug Delivery Sales by Application
5.1.1 Global Non-Invasive Drug Delivery Historical Sales by Application (2017-2022)
5.1.2 Global Non-Invasive Drug Delivery Forecasted Sales by Application (2023-2028)
5.1.3 Global Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
5.2 Global Non-Invasive Drug Delivery Revenue by Application
5.2.1 Global Non-Invasive Drug Delivery Historical Revenue by Application (2017-2022)
5.2.2 Global Non-Invasive Drug Delivery Forecasted Revenue by Application (2023-2028)
5.2.3 Global Non-Invasive Drug Delivery Revenue Market Share by Application (2017-2028)
5.3 Global Non-Invasive Drug Delivery Price by Application
5.3.1 Global Non-Invasive Drug Delivery Price by Application (2017-2022)
5.3.2 Global Non-Invasive Drug Delivery Price Forecast by Application (2023-2028)
6 North America
6.1 North America Non-Invasive Drug Delivery Market Size by Type
6.1.1 North America Non-Invasive Drug Delivery Sales by Type (2017-2028)
6.1.2 North America Non-Invasive Drug Delivery Revenue by Type (2017-2028)
6.2 North America Non-Invasive Drug Delivery Market Size by Application
6.2.1 North America Non-Invasive Drug Delivery Sales by Application (2017-2028)
6.2.2 North America Non-Invasive Drug Delivery Revenue by Application (2017-2028)
6.3 North America Non-Invasive Drug Delivery Market Size by Country
6.3.1 North America Non-Invasive Drug Delivery Sales by Country (2017-2028)
6.3.2 North America Non-Invasive Drug Delivery Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Non-Invasive Drug Delivery Market Size by Type
7.1.1 Europe Non-Invasive Drug Delivery Sales by Type (2017-2028)
7.1.2 Europe Non-Invasive Drug Delivery Revenue by Type (2017-2028)
7.2 Europe Non-Invasive Drug Delivery Market Size by Application
7.2.1 Europe Non-Invasive Drug Delivery Sales by Application (2017-2028)
7.2.2 Europe Non-Invasive Drug Delivery Revenue by Application (2017-2028)
7.3 Europe Non-Invasive Drug Delivery Market Size by Country
7.3.1 Europe Non-Invasive Drug Delivery Sales by Country (2017-2028)
7.3.2 Europe Non-Invasive Drug Delivery Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Non-Invasive Drug Delivery Market Size by Type
8.1.1 Asia Pacific Non-Invasive Drug Delivery Sales by Type (2017-2028)
8.1.2 Asia Pacific Non-Invasive Drug Delivery Revenue by Type (2017-2028)
8.2 Asia Pacific Non-Invasive Drug Delivery Market Size by Application
8.2.1 Asia Pacific Non-Invasive Drug Delivery Sales by Application (2017-2028)
8.2.2 Asia Pacific Non-Invasive Drug Delivery Revenue by Application (2017-2028)
8.3 Asia Pacific Non-Invasive Drug Delivery Market Size by Region
8.3.1 Asia Pacific Non-Invasive Drug Delivery Sales by Region (2017-2028)
8.3.2 Asia Pacific Non-Invasive Drug Delivery Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Non-Invasive Drug Delivery Market Size by Type
9.1.1 Latin America Non-Invasive Drug Delivery Sales by Type (2017-2028)
9.1.2 Latin America Non-Invasive Drug Delivery Revenue by Type (2017-2028)
9.2 Latin America Non-Invasive Drug Delivery Market Size by Application
9.2.1 Latin America Non-Invasive Drug Delivery Sales by Application (2017-2028)
9.2.2 Latin America Non-Invasive Drug Delivery Revenue by Application (2017-2028)
9.3 Latin America Non-Invasive Drug Delivery Market Size by Country
9.3.1 Latin America Non-Invasive Drug Delivery Sales by Country (2017-2028)
9.3.2 Latin America Non-Invasive Drug Delivery Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Non-Invasive Drug Delivery Market Size by Type
10.1.1 Middle East and Africa Non-Invasive Drug Delivery Sales by Type (2017-2028)
10.1.2 Middle East and Africa Non-Invasive Drug Delivery Revenue by Type (2017-2028)
10.2 Middle East and Africa Non-Invasive Drug Delivery Market Size by Application
10.2.1 Middle East and Africa Non-Invasive Drug Delivery Sales by Application (2017-2028)
10.2.2 Middle East and Africa Non-Invasive Drug Delivery Revenue by Application (2017-2028)
10.3 Middle East and Africa Non-Invasive Drug Delivery Market Size by Country
10.3.1 Middle East and Africa Non-Invasive Drug Delivery Sales by Country (2017-2028)
10.3.2 Middle East and Africa Non-Invasive Drug Delivery Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Adherium Limited
11.1.1 Adherium Limited Corporation Information
11.1.2 Adherium Limited Overview
11.1.3 Adherium Limited Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Adherium Limited Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Adherium Limited Recent Developments
11.2 Capsule Technologies, Inc.
11.2.1 Capsule Technologies, Inc. Corporation Information
11.2.2 Capsule Technologies, Inc. Overview
11.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Capsule Technologies, Inc. Recent Developments
11.3 Crossject S.A.
11.3.1 Crossject S.A. Corporation Information
11.3.2 Crossject S.A. Overview
11.3.3 Crossject S.A. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Crossject S.A. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Crossject S.A. Recent Developments
11.4 Diabeloop SA
11.4.1 Diabeloop SA Corporation Information
11.4.2 Diabeloop SA Overview
11.4.3 Diabeloop SA Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Diabeloop SA Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Diabeloop SA Recent Developments
11.5 HNS International, Inc.
11.5.1 HNS International, Inc. Corporation Information
11.5.2 HNS International, Inc. Overview
11.5.3 HNS International, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 HNS International, Inc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 HNS International, Inc. Recent Developments
11.6 Inovio Pharmaceuticals, Inc.
11.6.1 Inovio Pharmaceuticals, Inc. Corporation Information
11.6.2 Inovio Pharmaceuticals, Inc. Overview
11.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Inovio Pharmaceuticals, Inc. Recent Developments
11.7 Medtronic Plc.
11.7.1 Medtronic Plc. Corporation Information
11.7.2 Medtronic Plc. Overview
11.7.3 Medtronic Plc. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Medtronic Plc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Medtronic Plc. Recent Developments
11.8 Novartis AG
11.8.1 Novartis AG Corporation Information
11.8.2 Novartis AG Overview
11.8.3 Novartis AG Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Novartis AG Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis AG Recent Developments
11.9 PenJet Corporation
11.9.1 PenJet Corporation Corporation Information
11.9.2 PenJet Corporation Overview
11.9.3 PenJet Corporation Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 PenJet Corporation Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PenJet Corporation Recent Developments
11.10 PharmaJet
11.10.1 PharmaJet Corporation Information
11.10.2 PharmaJet Overview
11.10.3 PharmaJet Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 PharmaJet Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 PharmaJet Recent Developments
11.11 Portal Instruments
11.11.1 Portal Instruments Corporation Information
11.11.2 Portal Instruments Overview
11.11.3 Portal Instruments Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Portal Instruments Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Portal Instruments Recent Developments
11.12 ResMed
11.12.1 ResMed Corporation Information
11.12.2 ResMed Overview
11.12.3 ResMed Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 ResMed Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ResMed Recent Developments
11.13 Sensiron AG
11.13.1 Sensiron AG Corporation Information
11.13.2 Sensiron AG Overview
11.13.3 Sensiron AG Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Sensiron AG Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sensiron AG Recent Developments
11.14 Tandem Diabetes Care, Inc.
11.14.1 Tandem Diabetes Care, Inc. Corporation Information
11.14.2 Tandem Diabetes Care, Inc. Overview
11.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Tandem Diabetes Care, Inc. Recent Developments
11.15 Teva Pharmaceuticals Industries Ltd.
11.15.1 Teva Pharmaceuticals Industries Ltd. Corporation Information
11.15.2 Teva Pharmaceuticals Industries Ltd. Overview
11.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Teva Pharmaceuticals Industries Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-Invasive Drug Delivery Industry Chain Analysis
12.2 Non-Invasive Drug Delivery Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-Invasive Drug Delivery Production Mode & Process
12.4 Non-Invasive Drug Delivery Sales and Marketing
12.4.1 Non-Invasive Drug Delivery Sales Channels
12.4.2 Non-Invasive Drug Delivery Distributors
12.5 Non-Invasive Drug Delivery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Non-Invasive Drug Delivery Industry Trends
13.2 Non-Invasive Drug Delivery Market Drivers
13.3 Non-Invasive Drug Delivery Market Challenges
13.4 Non-Invasive Drug Delivery Market Restraints
14 Key Findings in The Global Non-Invasive Drug Delivery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer